Odontogenic Myxoma In Children: A Case Report And Literature Review by Contrera Toro et al.
Case Report
Odontogenic Myxoma in Children: A Case Report and
Literature Review
Mariana Dalbo Contrera Toro,1,2 Icléia Siqueira Barreto,1,3
Eliane Maria Ingrid Amstalden,1,3 Carlos Takahiro Chone,1,2
and Leopoldo Nizam Pfeilsticker1,4
1Department of Otorhinolaryngology, Head & Neck Surgery, State University of Campinas (UNICAMP), P.O. Box 6111,
13081-970 Campinas, SP, Brazil
2Department of Ear, Nose, Throat and Head & Neck Surgery, Unicamp, Brazil
3Department of Pathology, Unicamp, Brazil
4ENT, Maxillo Facial, Maxilo Facial ENT Service, Unicamp, Brazil
Correspondence should be addressed to Mariana Dalbo Contrera Toro; mdctoro@gmail.com
Received 29 September 2015; Accepted 7 February 2016
Academic Editor: Guido Fadda
Copyright © 2016 Mariana Dalbo Contrera Toro et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
Benign odontogenic lesions are rare entities but are very important due to their locally aggressive nature. Odontogenic myxoma
is even rarer in children than in adults. There is no evidence in the literature in regard to the best treatment approach, in terms of
conservative or aggressive surgery, for this type of tumor.This paper reports a case of odontogenic myxoma in a child treated with a
compromised approach through bone osteotomies and a review of the literature about this disease, especially in pediatric patients.
1. Introduction
Odontogenic myxoma is a rare tumor that occurs in the mes-
enchymal tissue of the mandible and maxilla and represents
3–6% of all odontogenic tumors. Despite its benign character,
it can be locally aggressive and has a recurrence rate of 25%
[1]. It is usually diagnosed in the third decade of life and has
no gender predilection [2]. In children, it can occur even
less frequently than in adults but tends to have the same
pathologic and clinical features.
Most patients are asymptomatic at diagnosis and typically
only present with image findings of the tumor. However,
the tumor can also present as a facial deformity with no
associated pain or inflammation [2].
The diagnosis consists of clinical findings along with
an image study (radiography, tomography, and MRI) but
can only be confirmed by histologic analysis. Radiography
usually shows a mandibular or maxillary tumor that is
unilocular with trabeculae and that is sometimes associated
with tooth displacement. Tomography shows a radiolucent
tumor with trabeculation, and although typical radiography
can be enough for diagnosis, CT and MRI are essential to
surgical planning and the evaluation of the tumor extension
[3].
There is no evidence-based consensus in terms of treat-
ment of the odontogenic myxoma. A literature review
demonstrated a large spectrumof surgical treatments varying
from conservative enucleation of the tumor to aggressive
resections such as mandibulectomy and maxillectomy. This
study reports a rare case of odontogenic myxoma in a pedi-
atric patient and discusses diagnosis and treatment options
according to a literature review.
2. Materials and Methods
This is a clinical retrospective study of medical records of one
patient who underwent surgical treatment for odontogenic
myxoma.
Moreover, a review of the medical literature in PubMed
and Scopus database was performed, covering articles pub-
lished in Portuguese or English and using the following
keywords (MeSH): “myxoma, odontogenic myxoma”.
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Figure 1: Face asymmetry before surgery.
The medical records of the subjects were used in this
review and all the parameters of the surgical procedure and
related devices were detailed.
2.1. Ethics. The institutional review board approved this
study, and all subjects gave written informed consent.
3. Case Report
A male patient, 2 years and 5 months old, presented at
the otorhinolaryngology outpatient clinic with parents com-
plaining of an enlargement and hardening of left maxilla
region for 2 weeks (Figure 1). The parents denied a history of
fever, weight loss, pain, secretion, surgery, dental procedures,
or trauma. Physical examination showed a 2.5 cm lesion
with fibroelastic characteristics and no signs of infection.
Oroscopy, otoscopy, and neck examination showed no alter-
ations.
A face tomography was completed and revealed a maxil-
lary sinus cyst with odontogenic origin and associated bone
erosion (Figure 2). Therefore, the main diagnosis hypothesis
was odontogenic cyst, and the patient was submitted to
surgery (Figure 3).
Access was obtained through a sublabial incision at
anterior left maxilla wall, and a dissection along anatomical
planes through the cyst wall covered by a bone capsule was
performed (Figure 3(a)).Thereafter, dissection along the cyst
limits and identification of bone erosion were performed
(Figure 3(b)). Peripheral osteotomies in all the surrounding
bone that was in direct contact with the lesionweremade, and
this bone was removed with a cutter (Figures 3(c) and 3(d)).
Additionally, resection of the cyst through the opening of the
bone capsule was followed by removal of the dental germs.
The cyst had a gelatinous mass characteristic (Figure 3(e)).
The patient was discharged from hospital at the first day
after surgery with no complaints and with antibiotics and
local care (cleaning of the incision site and ice compresses).
The histology showed a lesion with an ill lobular appear-
ance, surrounded by alveolar bone tissue. It is compounded
by a cytologically bland spindled and stellated-shaped cells
proliferation in an abundant, loose myxoid stroma that
contains few collagen fibrils and delicate vessels (Figure 4).
Table 1: Immunohistochemical panel.
Vimentin Diffusely positive
CD34 Negative (positive control: vessel)
AE1/AE3 Negative (positive control: epithelial componentof local developing teeth germs)
Desmin Negative
S-100 Negative
1A4 Focus of positivity
Myogenin Negative
Ki67 5–8% of the cells
An immunohistochemistry analysis showed a diffuse expres-
sion against vimentin antibody, with focal reactivity for
muscle-specific actin (Table 1 and Figure 5), favoring fibrob-
lastic proliferation with somemyofibroblastic differentiation.
Twomonths after the surgery, the patient’s parents denied
complaints, and a new tomography was requested, which
showed no evidence of recurrence (Figure 6).
4. Discussion
According to the World Health Organization (WHO), odon-
togenic myxoma is an intraosseous benign but infiltrative
neoplasm, classified under odontogenic tumors derived from
mesenchyme and/or odontogenic ectomesenchyme with or
without odontogenic epithelium. Histopathological features
include spindle-shaped and round cells in an abundant loose
mucoid/myxoid stroma with few collagen fibrils. Capillar-
ies, odontogenic epithelium, mast cells, plasmacytoid, and
residual bony trabeculae can also be found [4]. Immuno-
histochemistry findings reveal vimentin expression but not
cytokeratin, desmin, or neurofilaments [5]. This tumor can
also present as a capsule, which can be associated with
the locally aggressive nature of the neoplasm. Odontogenic
tumors are a rare entity in children. Fang et al. presented
a series of 310 cases of odontogenic tumors or tumor-like
lesions in which four patients had myxoma, and all patients
underwent aggressive surgery, with no recurrence observed
[6]. Recurrence rates for myxomas in the literature vary from
5 to 10%: however, there is no consensus information in the
literature [7].
Due to its slow growing characteristic, patients typically
do not have many symptoms, and an investigation with CT
and MRI is essential both for surgical planning and for
differential diagnosis with lesions that could contraindicate
biopsy [5]. A wide resection with 10 to 15mm margins is
recommended because of the high recurrence rates. Never-
theless, there is no guideline concerning surgical approach
in these patients, and some authors note that enucleation
and curettage can be effective and less aggressive, considering
large resections along with bone grafting and rehabilitation
being necessary [1, 2, 5, 8]. Boffano et al. suggested con-
servative surgery by enucleation and curettage when lesions
were smaller than 3 cm, whereas a segmental resection with
immediate reconstruction is favored in patients with larger
lesions [9].
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Figure 2: Coronal axial and sagittal CT: odontogenic myxoma left maxilla.
(a) (b) (c) (d)
(e)
Figure 3: Surgery steps 2 to 5. *Dental germ removal.
Kleiber et al. presented a very aggressive case of myxoma
with both mandible and maxillae commitment in a three-
year-old patient who underwent two surgical procedures
and previous chemotherapy. After a large resection, this
patient did not experience disease recurrence over a 4-
year follow-up period [10]. Kiresur and Hemavathy also
performed an extended resection of the jaw in a 17-year-
old patient because resection procedures minimize the risk
of involvement of vital structures and reduce the recurrence
rate [11]. Limdiwala and Shah described two odontogenic
myxomas of the maxillae, both in adults that underwent
conservative surgery, but follow-up was not described in this
paper [12].
Kawase-Koga et al. presented a literature review of 44
cases with patients (50% male) presenting a median age
of 31.9 years. Forty-five percent underwent conservative
surgery, and, in this group, a 15% recurrence rate was
observed. The other patients underwent radical procedures,
and, in this group, no recurrence was presented. The follow-
up was a median length of 46 months. Within those cases,
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(a) (b)
Figure 4: Odontogenic myxoma: (a) H&E ×10: a lobular and loose myxomatous tumor surrounded by alveolar bone. (b) H&E ×20: note the
spindle and stellate cells in a myxoid stroma with few collagen fibrils and delicate capillary vasculature.
(a) (b)
(c) (d)
Figure 5: Immunohistochemical analysis: (a) diffuse positivity for vimentin, (b) focal expression for 1A4 auto control: vessels wall, (c) AE1-
AE3 negative, and (d) Ki-67 expression around 5–8% of the nuclei.
three cases were children that were 6, 7, or 12 years old;
one of those children underwent radical surgery, but none
of the children presented with recurrence [2]. Kadlub et al.
presented a review of 20 cases of infants (under two years old)
with odontogenic myxoma. These patients had a median age
of 14,9 months, and all cases hadmaxilla commitment; 62,5%
of the cases had conservative tumor resection, of which one
presented recurrence.Themedian follow-upwas 2,84months
[1]. This patient was subjected to peripheral osteotomies,
which is a compromise between aggressive bone resection
and conservative cyst extraction or curettage. Although there
is only a one-year follow-up period, this technique showed
great effectiveness.
Based on histopathologic features a myxoma may be
confused with other myxoid neoplasms of the jaw, such
as the rare chondromyxoid fibroma or myxoid neurofi-
broma; the first could have areas of cartilaginous dif-
ferentiation, whereas myxoid neurofibromas tend to have
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Figure 6: Coronal, axial, and 3D bone reconstruction showing no recurrence of the maxillary lesion.
scattered lesional cells, similar to myxoma, but both of
these tumors are positive for S-100 protein, which is not
observed on odontogenic myxoma [13]. Also the bland
cellularity of the myxoma and the negativity for desmin
and Myogenin speak against a botryoid-type embryonal
(myxoid) rhabdomyosarcoma, of the head and neck in
children. Myxoid change in an enlarged dental follicle or the
dental papilla of a developing tooth may be microscopically
similar to a myxoma, but the clinical, radiographic features
and all the pathologic and immunohistochemical findings
observed, in this case, favor the diagnosis of an odontogenic
myxoma.
There is a large spectrum of differential diagnosis of
odontogenic raging from benign to malignant diseases, in
both children and adults. Especially concerning children, the
diagnosis prior to surgery is essential because a functional
and esthetic defect can be more complex, even considering
a recurrence rate [7]. Consequently, a follow-up is extremely
necessary in the two years after surgery, when recurrences
occur more often, but it is also recommended that these
patients never get discharged from the outpatient clinic
[2].
5. Conclusion
Odontogenic myxoma at pediatric ages is a rare pathology;
therefore, few studies have been performed in this field.
Differential diagnosis is essential in children, and CT and
MRI have important roles in this process.
The evidence supports conservative resections in these
patients due to the higher morbidity of aggressive surgeries.
This paper also presents a middle ground between aggressive
and conservative surgery by peripheral osteotomies. There
is a need for evidence-based recommendation in terms
of treatment of those cases. Especially in infants, long-
term follow-up is important due to the recurrent nature
of this disease and the long-term life expectancy in these
patients.
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